<DOC>
	<DOC>NCT01047605</DOC>
	<brief_summary>To evaluate the pharmacological effects of two herbal medicinal products (Neurapas balance and Pascoflair 425 mg) in comparison to placebo on brain activity.</brief_summary>
	<brief_title>Pharmacological Effects of Neurapas® Balance and Pascoflair® 425 mg on Brain Activity in Healthy Volunteers</brief_title>
	<detailed_description>Evaluation of the pharmacological effects of Neurapas® balance and Pascoflair® 425 mg by quantitative measurement of brain activity in 16 healthy volunteers.</detailed_description>
	<criteria>Healthy male and female volunteers 30 70 years (extremes included) Medical history without any study relevant pathological findings Written and signed informed consent Clinically study relevant acute or chronic disorders, that can be detected by clinical investigation or medical history Clinical, studyrelevant pathological findings of clinical oar laboratory investigations Clinically relevant pathological EEG findings (e.g. artefactfree parts in ScreeningEEG &lt;30% in one recording Clinically relevant allergies positive alcohol testing on Screening, Day A, B, or C, or anamnestic positive drug screening test on Screening, Day A, B, or C, or anamnestic Intake of study relevant medication 14 days prior to active Day A, or during active study duration, based on the volunteer´s information Regular intake of drug with primary central nervous effects (e.g. psychoactive drugs or central acting antihypertensive drugs) Known hypersensitivity / allergy against herbal extracts (i.e. dry extracts of Passionflower herb, St. John´s Wort herb, Valerian root) or lactose or an other excipient of the investigational medication Lapplactase deficiency (anamnestic) Hypersensitivity of the skin (anamnestic) BMI (BodyMassIndex) &lt;18 or&gt;30 Abuse of caffeine, teeine, or tobacco Smoking in the investigational site on Day A, B, or C Participation in an other clinical study within 60 days prior to Screening Positive Pregnancy Test (on Screening, Day A, B, or C) or Lactation Bad compliance Revocation of informed consent</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>qEEG</keyword>
	<keyword>herbal medicine</keyword>
	<keyword>cognitive function</keyword>
	<keyword>Neurapas balance</keyword>
	<keyword>Pascoflair</keyword>
	<keyword>hypericum</keyword>
	<keyword>passionflower</keyword>
	<keyword>valerian</keyword>
	<keyword>Healthy volunteers</keyword>
	<keyword>Influence on quantitative electro-encephalogram (qEEG).</keyword>
</DOC>